This study provides new insights into the protumorigenic role of HORMAD1 and the regulatory mechanism by which it regulates the Wnt/β-catenin pathway in lung cancer progression and indicates that HORMAD1 may be a potential therapeutic target for lung cancer. Here, HORMAD1 is linked to lung cancer.